Stocks Health care STME

OTC · Health care

Stimcell Energetics Inc. (STME)

It posted a net loss of $895.4K. At May 31, 2026 it held $3.1K in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on August 31, 2026.

Watch STME in 60 seconds

What Stimcell Energetics Inc. does

Stimcell Energetics Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker STME.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Stimcell Energetics Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 8, 2026
   Material agreement 8-K
2. August 31, 2026
   Annual report 10-K · period to May 31, 2026Diluted EPS -$0.04 versus -$0.03.
3. April 10, 2026
   Quarterly report 10-Q · period to February 28, 2026Diluted EPS $0.00 versus -$0.01.
4. March 20, 2026
   Material agreement 8-K
5. January 15, 2026
   Quarterly report 10-Q · period to November 30, 2025Diluted EPS -$0.01 versus -$0.01.
6. January 15, 2026
   Late quarterly report notice NT 10-Q
7. December 2, 2025
   Investor disclosure 8-K
8. October 14, 2025
   Quarterly report 10-Q · period to August 31, 2025Diluted EPS -$0.01 versus $0.00.
9. September 2, 2025
   Annual report 10-K · period to May 31, 2025Diluted EPS -$0.03 versus -$0.01.
10. September 2, 2025
    Late annual report notice NT 10-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on December 19, 2025. Insider transactions on SEC

Insider trades

What the people running Stimcell Energetics Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns STME

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

We have not read this company's Schedule 13D and 13G filings yet.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 4,164,566 shares in total, about $916.2K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about STME

What does Stimcell Energetics Inc. do?

Stimcell Energetics Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker STME.

Is Stimcell Energetics Inc. profitable?

No. In fiscal 2026 it reported a net loss of $895.4K.

When did Stimcell Energetics Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on August 31, 2026. It covers the period to May 31, 2026. Its newest filing of any kind is the material agreement from September 8, 2026.

Similar companies

Compare STME with

Compare STME with any company

Follow STME

Get an email when Stimcell Energetics Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow STME: get an email when it files

Where the numbers come from

Financial figures are the values Stimcell Energetics Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.